Associated Partner

Karolinska Institutet

Stockholm,

Sweden

Karolinska Institutet (KI) in Sweden is one of the world’s foremost medical universities, and accounts for the single largest share of all academic medical research conducted in Sweden. KI also offers the country’s broadest range of education in medicine and health sciences. The Nobel Assembly at KI selects the Nobel laureates in Physiology and Medicine.

In this project, Karolinska Institutet will be involved in data aggregation (WP1) and social innovation (WP6).

Key People Involved:

Professor Richard Rosenquist Brandell

MD, PhD, Dept. of Molecular Medicine and Surgery, Karolinska Institutet

Professor Janne Lehtiö

PhD, Dept. of Oncology-Pathology, Karolinska Institutet

Professor Simon Ekman

MD, Senior Physician, Department of Oncology-Pathology, Karolinska Institutet

partners

Beneficiaries & Associated Partners

Beneficiary

Instituto Português de Oncologia do Porto FG, EPE (IPO-Porto)

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Associated Partner

Center for Personalized Cancer Treatment hosted by Radboud University Medical Center

Participation in WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).

Beneficiary

Helsinki University Hospital (HUS)

Work package leader dissemination (WP8). Will in addition contribute to WP1 (data aggregation), WP3 (expansion cohorts) and WP6 (social innovation).